Raddisun Pharmachem Industries Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 2.00 M
as on 24-10-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.45 Cr
as on 24-10-2024
- Revenue -55.48%
(FY 2023)
- Profit -75.94%
(FY 2023)
- Ebitda -86.46%
(FY 2023)
- Net Worth 4.93%
(FY 2023)
- Total Assets -2.95%
(FY 2023)
About Raddisun Pharmachem Industries
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹3.50 Cr. The company has closed loans amounting to ₹2.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Balkrishna Kanakia, Dhaval Kanakia, and Akshay Kanakia serve as directors at the Company.
- CIN/LLPIN
U24110MH2012PTC227154
- Company No.
227154
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raddisun Pharmachem Industries?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balkrishna Kanakia  | Director | 18-Feb-2012 | Current |
| Dhaval Kanakia | Director | 01-Dec-2013 | Current |
| Akshay Kanakia | Director | 01-Dec-2013 | Current |
Financial Performance of Raddisun Pharmachem Industries.
Raddisun Pharmachem Industries Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 55.48% decrease. The company also saw a substantial fall in profitability, with a 75.94% decrease in profit. The company's net worth moved up by a moderate rise of 4.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raddisun Pharmachem Industries?
In 2023, Raddisun Pharmachem Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Ultimate Chem (India) Private LimitedActive 25 years 10 monthsBalkrishna Kanakia is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 23 Mar 2021 | ₹3.50 Cr | Open |
Others Creation Date: 08 May 2020 | ₹1.98 M | Satisfied |
Others Creation Date: 09 Mar 2015 | ₹2.25 Cr | Satisfied |
How Many Employees Work at Raddisun Pharmachem Industries?
Unlock and access historical data on people associated with Raddisun Pharmachem Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raddisun Pharmachem Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raddisun Pharmachem Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
